The standard ISO 10993-1:2009 “Biological evaluation of medical devices – Part 1: Evaluation and testing” describes the strategy for the biological safety evaluation of a medical device with direct or indirect body contact. However, according to this standard first the suitability of a material regarding the physical and chemical characteristics should be evaluated: “In the selection of materials to be used in device manufacture, the first consideration shall be fitness for purpose with regard to characteristics and properties of the material, which include chemical, toxicological, physical, electrical, morphological and mechanical properties. […] Identification of material chemical constituents and consideration of chemical characterization (see ISO 10993-18) shall precede any biological testing […]”..

For the material characterization of medical devices ISO 10993-18:2005 “Biological evaluation of medical devices – Part 18: Chemical characterization of materials” was issued as a guideline. The material characterization supports the manufacturer at an early stage to evaluate the critical material properties or leachable chemical substances. Furthermore, during the development of new products an identification and quantification of possible degradation products has to be performed in accordance with ISO 10993-9, ISO 10993-13 (polymers), ISO 10993-14 (ceramics) and ISO 10993-15 (metals and alloys). All identified leachable and degradation products should be subjected to a toxicological evaluation in order to estimate its toxicological risk during application of the device under evaluation.


Analytical-ChemistryUL uses numerous modern analytical test procedures, like GC/MS, HPLC, FTIR, ICP, XPS and SEM/EDX to help you perform the required physicochemical analyses.

  • Material Characterization of Medical Devices
  • Physicochemical Analyses of Polymeric Materials
  • Metal and Ceramic Analyses
  • Residue Analyses
  • Toxicological Evaluation of Leachables and Degradation Products



Global Market Acceptance

  • 120 year business experience
  • Operates in more than 143 countries
  • UL has issued more CB Test Certificates than any other body
  • UL reports and certifications are recognized and accepted around the world
  • UL Marks appear on more than 22 billion products globally
Comprehensive Testing & Certification Services

  • UL offers field evaluations, onsite training and can come to you for testing
  • Full compliance testing/evaluation to pre-scans and other preliminary testing
  • UL has engineers that work with you from design through conception and production
  • UL’s engineers average 10 plus years in the industry
  • UL has over 11 industries business units in the UL company portfolio


Knowledge of Global Standards and Regulatory Requirements

  • Covers many markets ie FDA (US), MFDS (Korean FDA), EU IVD, EU MDD
  • UL has helped to set more than 1,600 standards defining safety, security, quality and sustainability
  • UL Engineers partner with standard committees such as AAMI, ANSI and government bodies
  • UL has an FDA recognized consensus standard, UL 2900, for cybersecurity
State of the Art Facilities

  • 159 UL laboratories for testing and certification world wide
  • Tailored testing solutions, using software automation to enhance process efficiency, analyze results and reduce testing cycles
  • Over 10 Accredited UL laboratories around the world